# Progress Note 07 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Robert Falcon Scott (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX002-SYN
- Date: 2026-05-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ottilie Harrow-Mbeki, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Pre-departure review: blood pressure on losartan, mental health, and the expedition medical plan. **S**

## History of present illness

Mr. Scott returns about three weeks before the expedition leaves. The gastroenteritis three weeks ago settled within three days; he held losartan for two days and restarted it once he was eating normally. His home readings over the last week average 124/78 mmHg on losartan 50 mg, and he has had no lightheadedness since the illness. He has not smoked for eighteen weeks and takes varenicline. The sledging rations and the vitamin C tablets are packed. He wants to know what the medical plan is if he or another man falls ill far from the hut, and how he can look after his mind and his sleep through the polar winter and the long journeys. **S**

| Element | Detail |
|---|---|
| Home blood pressure | Seven-day average 124/78 mmHg on losartan |
| Recent illness | Gastroenteritis resolved; losartan held for two days under the sick-day rule |
| Tobacco | No pipe for eighteen weeks |
| Mood and sleep | PHQ-9 2, GAD-7 3; sleeping six to seven hours |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, or swelling |
| Neurological | Negative | No lightheadedness on standing since the illness |
| Gastrointestinal | Negative | Bowels normal; eating well |
| Psychiatric | Negative | Mood good; some worry about the timetable; sleeping well |

4 systems reviewed. **S**

## Current medications

- Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration (0.5 mg once daily for 3 days, then twice daily for 4 days) **S**
- Losartan 50 mg tablet, one tablet by mouth daily; stop during vomiting, diarrhea or dehydration and restart when eating and drinking normally **S**
- Vitamin C (ascorbic acid) 250 mg tablet, one tablet by mouth daily whenever no fresh food is available, packed in every sledging ration **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/78 mmHg; pulse 60 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 70.8 kg; BMI 23.7 kg/m². All vital signs are synthetic.

Sodium: 140 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 0.94 mg/dL; eGFR: 104 mL/min/1.73 m²; PHQ-9: 2; GAD-7: 3. All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 140 mmol/L at this visit **S**
- Potassium: 4.2 mmol/L at baseline, 4.4 mmol/L at this visit **S**
- Creatinine: 0.92 mg/dL at baseline, 0.94 mg/dL at this visit **S**
- eGFR: 107 mL/min/1.73 m² at baseline, 104 mL/min/1.73 m² at this visit **S**
- PHQ-9: 3 at baseline, 2 at this visit **S**
- GAD-7: 4 at baseline, 3 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 124/78, pulse 60, weight 70.8 kg, BMI 23.7 |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Mouth | Gums firm and pink |
| Extremities | Normal capillary refill in the fingers and toes; no skin damage on the feet |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Essential hypertension, at target on losartan** (I10). Home average 124/78 mmHg and office 124/78, at target. Five weeks after starting losartan: sodium 140, potassium 4.4 mmol/L, creatinine 0.94 mg/dL (eGFR 104), back to his baseline after the rise to 1.16 mg/dL during the gastroenteritis. **S**
   - Continue losartan 50 mg daily; six months' supply plus three months' spare, split between two kits.
   - Sick-day rule, in writing, in the medical kit.
   - Electrolytes and creatinine about six months after starting, if the expedition has the means, otherwise on his return.
2. **Nicotine dependence, pipe tobacco, in early remission** (F17.290). Abstinent for eighteen weeks. **S**
   - Varenicline to the end of the second course; no tobacco in his kit.
3. **Fitness for a long polar expedition**. Fit to sail and to take part in the sledge journeys, with the plan below. PHQ-9 2 and GAD-7 3 before departure, as at intake. **S**
   - Nutrition: about 5,000 to 6,500 kcal a day on man-hauling journeys with a high fat share; weigh weekly in the hut and add rations for loss of more than 5% of body weight; fresh seal meat when available; vitamin C 250 mg daily when no fresh food is available; weekly check of gums and legs, with any bleeding gums, bruising, or swollen legs reported at once.
   - Cold injury: layered dry clothing, spare mitts and socks, checks of each other's faces, hands, and feet at every halt; field rewarming of frostbitten tissue in warm water at 37 to 39 °C only when it can be kept from refreezing, with ibuprofen; hypothermic casualties insulated and handled gently.
   - Altitude: gradual ascent to the polar plateau, with acetazolamide in the medical kit for acute mountain sickness.
   - Mental health and sleep: a fixed daily routine, regular meals, daylight or bright light in the polar winter and eye masks in constant daylight, a PHQ-9 and GAD-7 self-check each month, a named person in the party to talk to, and a telemedicine contact with the clinic when communication allows.
   - Evacuation and communication: a written plan with satellite messaging where it reaches, the evacuation windows by season, and the understanding that for much of the year no evacuation is possible, so the medical kit and training must carry the party.
   - Medical summary, medicine list, and the advance care plan to travel in the medical kit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, validated technique, average of two readings (target below 130/80 mmHg) | Every visit | Completed today | 124/78 mmHg, at target |
| Self-management | Home blood pressure monitoring to confirm the diagnosis and guide treatment | At diagnosis and when treatment changes | Completed today | Seven-day average 124/78 mmHg on losartan |
| Examination | Weight, BMI, and cardiac auscultation | Every visit | Completed today | 70.8 kg, BMI 23.7; no murmur |
| Laboratory | Basic metabolic panel: sodium, potassium, creatinine, eGFR | Baseline; 2 to 4 weeks after starting an ARB; then every 6 months on an ARB | Completed today | Sodium 140, potassium 4.4 mmol/L, creatinine 0.94 mg/dL, eGFR 104, five weeks after starting losartan; the two-week check fell during the gastroenteritis (creatinine 1.16 mg/dL); next at about six months |
| Medication safety | Medication adherence, side effects, and sick-day rules | Every visit | Completed today | Losartan taken daily apart from two days held correctly under the sick-day rule; no lightheadedness |
| Laboratory | Urine albumin-to-creatinine ratio | At diagnosis, then yearly | Up to date | 8 mg/g at the six-week visit; next in a year |
| Laboratory | Lipid panel and HbA1c or fasting glucose | At diagnosis, then yearly | Up to date | At intake; next in a year |
| Examination | Fundoscopic examination | Yearly | Up to date | Normal at the preventive visit |
| Survey | PHQ-9 depression screen | Yearly with hypertension, and before and after a long isolated posting | Completed today | PHQ-9 2 |
| Survey | GAD-7 anxiety screen | Before and after a long isolated posting | Completed today | GAD-7 3 |
| Self-management | Tobacco use and cessation support (varenicline with counseling) | Every visit | Completed today | Abstinent for eighteen weeks |
| Self-management | Expedition nutrition plan: energy, weight, and vitamin C | Planned before departure, then weekly in the field | Completed today | Energy targets, weekly weights, and vitamin C 250 mg daily when no fresh food is available; supply packed |
| Self-management | Frostbite and hypothermia prevention and field treatment training | Before departure | Up to date | Course completed at the three-month visit |
| Self-management | Altitude plan for the polar plateau | Before ascent | Completed today | Gradual ascent; acetazolamide in the medical kit |
| Self-management | Mental health and sleep support plan for isolation | Before departure, then monthly in the field | Completed today | Routine, light management, monthly self-checks, and a named contact agreed |
| Self-management | Evacuation, communication, and medical kit plan | Before departure | Completed today | Written plan, communication schedule, medicine supply, and medical summary in the kit |

## Goal progress

- Home blood pressure average below 130/80 mmHg before departure. Outcome by 2026-05-26: Home average 124/78 mmHg on losartan 50 mg. **S**
- No tobacco from the quit date, confirmed at each visit. Outcome by 2026-05-26: No pipe since the quit date a week after intake; varenicline continued for relapse prevention. **S**
- Complete a wilderness first aid course with frostbite, hypothermia and evacuation practice before departure. Outcome by 2026-04-21: Course completed, with rewarming and casualty-packaging practice. **S**
- A written expedition medical plan covering nutrition and vitamin C, cold injury, altitude, mental health support, medicines and evacuation, agreed before departure. Outcome by 2026-05-26: Plan agreed; a copy travels in the expedition medical kit. **S**

## Medication changes

- Started: Vitamin C (ascorbic acid) 250 mg tablet, one tablet by mouth daily whenever no fresh food is available, packed in every sledging ration **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Circulation 2025;152(11):e114-e218) (2025), American Heart Association and American College of Cardiology
- CMID: Clinical Monitoring Intelligence Database, hypertension monograph (2026), Aether Forge
- Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024), Wilderness Medical Society
- Wilderness Medical Society Clinical Practice Guidelines for the Out-of-Hospital Evaluation and Treatment of Accidental Hypothermia: 2019 Update (Dow J, et al. Wilderness Environ Med 2019;30(4S):S47-S69) (2019), Wilderness Medical Society
- Wilderness Medical Society Clinical Practice Guidelines for the Prevention, Diagnosis, and Treatment of Acute Altitude Illness: 2024 Update (Luks AM, et al. Wilderness Environ Med 2024;35(1 Suppl):2S-19S) (2024), Wilderness Medical Society
- Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (2000), Institute of Medicine, National Academies Press
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- Anxiety Disorders in Adults: Screening (2023), U.S. Preventive Services Task Force

## Follow-up

- Review on his return, with blood pressure, electrolytes and creatinine, urine albumin, lipids, PHQ-9 and GAD-7. Telemedicine contact with the clinic when communication allows. **S**

